PRIMED-AI: Multi-use Framework Playbooks (UG3 Clinical Trial Not Allowed)
ID: 359271Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359271
Timeline
    Description

    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "PRIMED-AI: Multi-use Framework Playbooks," aimed at supporting the development of AI-based tools that integrate clinical imaging with various health data types to enhance personalized medicine. This initiative seeks to fund projects that will create "playbooks" for the responsible use of PRIMED-AI models, focusing on error mitigation, data management, and regulatory preparation. With an estimated total program funding of $650,000, the opportunity is open to small businesses, and while applications are not currently being solicited, interested parties are encouraged to prepare for collaboration and project development ahead of the anticipated synopsis posting on July 1, 2025. For further inquiries, potential applicants can contact Dr. Sahana N. Kukke at ODPRIMED-AI@od.nih.gov or by phone at 301-402-3756.

    Point(s) of Contact
    Sahana N. Kukke, PhD Office of the Director/NIH Common Fund, DPCPSI, OD
    (301) 402-3756
    ODPRIMED-AI@od.nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    PRIMED-AI: Translating Models to Clinic (UG3/UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "PRIMED-AI: Translating Models to Clinic," aimed at developing innovative AI-based tools that integrate clinical imaging with multimodal health data to enhance personalized medicine for patients with chronic conditions. This initiative, part of the Precision Medicine with Artificial Intelligence program, will utilize a biphasic mechanism focusing initially on rigorous AI model building through the analysis of large datasets, with successful projects advancing to evaluate the clinical utility of AI-driven Clinical Decision Support tools. The estimated total program funding is $10.2 million, with applications expected to be solicited after the synopsis posting on July 1, 2025, and a closing date anticipated on November 1, 2025. Interested applicants can contact Dr. Sahana N. Kukke at ODPRIMED-AI@od.nih.gov or by phone at 301-402-3756 for further information.
    PRIMED-AI: Academic-Industrial Partnerships (UG3/UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing an upcoming funding opportunity titled "PRIMED-AI: Academic-Industrial Partnerships (UG3/UH3 Clinical Trial Optional)" aimed at developing innovative AI-based tools that integrate clinical imaging with multimodal health data to enhance personalized medicine for patients with chronic conditions. This initiative will focus on fostering collaborations between academic institutions and industry partners to improve data integration and interoperability, followed by algorithm development and performance testing in a subsequent phase. The estimated total program funding is $2.9 million, with applications expected to open in July 2025 and close in November 2025, while the anticipated award date is September 2026. Interested parties can reach out to Dr. Sahana N. Kukke at ODPRIMED-AI@od.nih.gov or by phone at 301-402-3756 for further information.
    PRIMED-AI: Validation Center (U54 Clinical Trial Not Allowed) 
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the upcoming opportunity for the PRIMED-AI: Validation Center program, which aims to develop AI-based tools that integrate clinical imaging with various health data types to enhance personalized medicine for patients with chronic conditions. This initiative will serve as an independent hub for the verification, validation, and uncertainty quantification of AI-enabled Clinical Decision Support (CDS) tools, focusing on the systematic retesting and harmonization of deliverables to characterize their performance comprehensively. The program is particularly relevant for small businesses with expertise in the validation of CDS tools, and while applications are not currently being solicited, interested parties are encouraged to prepare for future submissions. The estimated total program funding is $3,900,000, with key dates including a synopsis post date of July 1, 2025, and an estimated award date of September 1, 2026. For further inquiries, contact Sahana N. Kukke, PhD, at ODPRIMED-AI@od.nih.gov or call 301-402-3756.
    PRIMED-AI: Logistics Center (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "PRIMED-AI: Logistics Center," aimed at developing innovative AI-based tools that integrate clinical imaging with various health data types to enhance personalized medicine for patients with chronic health conditions. This initiative will establish a Logistics Center that provides administrative infrastructure through three integrated cores—Administration, Evaluation, and Outreach—to manage consortium activities, including governance, workshops, and community engagement. The estimated total program funding is $2,750,000, with applications not currently being solicited; however, potential applicants are encouraged to prepare for collaboration and project development ahead of the anticipated Notice of Funding Opportunity (NOFO) release on July 1, 2025. For further inquiries, interested parties may contact Dr. Sahana N. Kukke at 301-402-3756 or via email at ODPRIMED-AI@od.nih.gov.
    Forecast for Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) for the Blueprint MedTech Translator program, aimed at supporting small businesses in the development of innovative medical devices for the nervous and neuromuscular systems. This cooperative agreement will provide non-dilutive funding and additional resources to facilitate the translation of groundbreaking technologies from early-stage development to clinical studies, ultimately accelerating patient access to effective medical devices. Interested applicants should note that while applications are not currently being solicited, they are encouraged to begin forming collaborations and developing projects in anticipation of the NOFO, with an estimated synopsis posting date of July 21, 2025, and a closing date of October 20, 2025. For further inquiries, potential applicants can contact Nicholas Langhals, PhD, at Blueprint-MedTech@nih.gov or by phone at 301-435-0090.
    Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the Advancing Bioinformatics, Translational Bioinformatics, and Computational Biology Research initiative, which aims to support innovative research in these fields. This initiative seeks to develop advanced methods and tools that leverage transformative technologies, such as artificial intelligence and machine learning, to enhance the interpretation of complex biological datasets, ultimately improving health outcomes. With an estimated total program funding of $2.5 million and the expectation of awarding approximately 10 grants, interested small businesses are encouraged to prepare their applications, with the anticipated synopsis posting date on October 6, 2025, and a closing date for applications on February 4, 2026. For further inquiries, potential applicants can contact Dr. Catherine Farrell at catherine.farrell@nih.gov or by phone at 301-402-7081.
    Forecast for The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) for the NINDS Human Biospecimen and Data Repository, aimed at advancing research in neurological disorders. This initiative will establish a repository to maintain and expand a collection of biospecimens, which will be made available to qualified academic and industry researchers to support basic, translational, and clinical research efforts. The total estimated funding for this program is $1,950,000, with one award anticipated, and interested applicants are encouraged to begin forming collaborations and developing proposals ahead of the expected synopsis posting on August 25, 2025. For further inquiries, potential applicants can contact Dr. Rebecca Price at rebecca.price@nih.gov or by phone at 301-827-3587.
    Research Grants in Clinical Informatics (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming opportunity for research grants in Clinical Informatics, specifically under the R01 Clinical Trial Optional funding mechanism. This initiative aims to support innovative research that develops and evaluates clinical informatics tools and methodologies, enhancing the ability of clinicians and patients to manage health care delivery effectively. The program emphasizes the creation of scalable and reusable approaches to transform diverse health data into actionable insights, ultimately improving clinical workflows and health outcomes. With an estimated total funding of $2.5 million and the expectation of awarding approximately 10 grants, interested applicants are encouraged to prepare their proposals ahead of the anticipated application period, which is expected to open following the synopsis posting on October 6, 2025. For further inquiries, potential applicants can contact Goutham Reddy at goutham.reddy@nih.gov or by phone at 301-827-6728.
    Notice of Intent to Publish a Funding Opportunity Announcement for Impact of Technology and Digital Media Exposure Usage on Child and Adolescent Development
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at researching the impact of technology and digital media exposure on child and adolescent development. This initiative seeks to address the urgent need for understanding how various forms of technology and digital media, such as social media, video games, and artificial intelligence, affect children's health and development, as well as their interactions with family and peers. With an estimated total program funding of $3 million, the NIH encourages small businesses and collaborative teams with expertise in relevant fields to prepare for this opportunity, although applications are not currently being solicited. Interested parties can reach out to Brett Miller, Ph.D., at brett.miller@nih.gov or by phone at 301-496-9849 for further information, with the anticipated synopsis posting date set for March 1, 2026, and a projected award date of April 1, 2027.
    Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint MedTech: Prototype Developer (U18 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity announcement for the Blueprint MedTech: Prototype Developer program, aimed at supporting the development of human-grade medical device prototypes. This initiative will utilize the U18 activity code and is designed to assist projects in completing product definition and development, including needs assessment, product design, prototype development, and bench testing, ultimately preparing for first-in-human testing through subsequent FOAs. The program is significant for advancing medical technology and innovation in healthcare, with no cost-sharing or matching requirements. Interested applicants can reach out to Michael Wolfson, Ph.D., at 301-451-6987 or via email at Blueprint-MedTech@nih.gov for further information. The estimated synopsis post date was July 15, 2021, with applications expected to be due in Fall 2021, and the anticipated award date is June 1, 2022.